RZL

RZOLV starts North Vancouver pilot plant build, targeting Q1 2027 commissioning.

RZOLV reports 99.99% silver extraction in lab tests, but commercial viability remains unproven.

RZOLV hires Sophic Capital for IR, paying $9,000/month plus 500,000 options at $0.30.

Non-binding MOU signals early talks, not a commercial breakthrough or revenue event.

This is a high-hype, early-stage deal with no immediate investment impact or financial proof.

This is a straightforward capital raise, not a signal of imminent business transformation.

This is a memorial, not an investment update—no actionable company data is disclosed.

Early lab results look promising, but commercial success is distant and unproven.

Early-stage R&D progress, but no commercial proof or financial clarity for investors yet.

This is a basic financing announcement with no evidence of commercial traction or near-term upside.

Early technical promise, but commercial reality is years away and unproven.

All promise, no proof—investors get vision, not validation or near-term value.